S
Supernus Pharmaceuticals (SUPN)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Supernus Pharmaceuticals (SUPN)
Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. The Company offers Oxtellar XR (extended-release oxcarbazepine) and Trokendi XR (exten... Read more
- USD28.67
- USD29.53
- USD28.67
- USD39.09
- -15.60%
- 608M
- 361.63k
- 384.90k
- 1.7B
- 21.99
- -20.40%
- 17.60%
Stock News
49 minutes ago
Apple Has Been Left Behind in the AI Rally. Why It Might One Day Still Be the Big Winner.
Yahoo
yesterday
Cramer’s week ahead: Earnings from Tesla, Merck and Big Tech
CNBC
yesterday
TV and film jobs may never fully recover post-pandemic, strikes, says Teamsters president
CNBC
yesterday
KKR Real Estate Finance Trust Inc. Declares Preferred Stock Dividend
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
